Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice

Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease

(2016) Xianglan Yao et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Sphingosylphosphorylcholine inhibits macrophage adhesion to vascular smooth muscle cells

(2016) Christiane Wirrig et al.   BIOCHEMICAL PHARMACOLOGY

Retinal Neurons Curb Inflammation and Enhance Revascularization in Ischemic Retinopathies via Proteinase-Activated Receptor-2

(2015) Nicholas Sitaras et al.   AMERICAN JOURNAL OF PATHOLOGY

Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice

(2015) Tomoya Hara et al.   ATHEROSCLEROSIS

Effects of the Factor Xa Inhibitor, Fondaparinux, on the Stability of Atherosclerotic Lesions in Apolipoprotein E-Deficient Mice

(2015) Pengfei Zuo et al.   CIRCULATION JOURNAL

Macrophage Phenotypes and Their Modulation in Atherosclerosis

(2014) Federica De Paoli et al.   CIRCULATION JOURNAL

New Insights into the Vulnerable Plaque from Imaging Studies

(2014) Robert S. Fenning et al.   Current Atherosclerosis Reports

Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review

(2014) C. Roger White et al.   JOURNAL OF LIPID RESEARCH

Transactivation of the PAR1-PAR2 Heterodimer by Thrombin Elicits β-Arrestin-mediated Endosomal Signaling

(2013) Huilan Lin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages

(2011) Daniel Baitsch et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Protease-Activated Receptor-2 Modulates Protease-Activated Receptor-1–Driven Neointimal Hyperplasia

(2011) Leila M. Sevigny et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

ApoE Suppresses Atherosclerosis by Reducing Lipid Accumulation in Circulating Monocytes and the Expression of Inflammatory Molecules on Monocytes and Vascular Endothelium

(2011) Nathalie Gaudreault et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Interleukin-17A Deficiency Accelerates Unstable Atherosclerotic Plaque Formation in Apolipoprotein E-Deficient Mice

(2011) Keiko Danzaki et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe–/– mice during disease regression

(2011) Stephane Potteaux et al.   JOURNAL OF CLINICAL INVESTIGATION

Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice

(2011) Matthew R. Alexander et al.   JOURNAL OF CLINICAL INVESTIGATION

The immune system in atherosclerosis

(2011) Göran K Hansson et al.   NATURE IMMUNOLOGY

Protease-activated receptor 2 signaling in inflammation

(2011) Andrea S. Rothmeier et al.   Seminars in Immunopathology

Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis

(2010) T. A. McEachron et al.   BLOOD

Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients

(2010) Ying Ma et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Immune and Inflammatory Mechanisms of Atherosclerosis

(2009) Elena Galkina et al.   Annual Review of Immunology

The vulnerable and unstable atherosclerotic plaque

(2008) Michael C. Fishbein   CARDIOVASCULAR PATHOLOGY

Factor Xa: at the crossroads between coagulation and signaling in physiology and disease

(2008) Keren Borensztajn et al.   TRENDS IN MOLECULAR MEDICINE

Macrophages: An elusive yet emerging therapeutic target of atherosclerosis

(2007) R.L. Tiwari et al.   MEDICINAL RESEARCH REVIEWS